Next Generation Sequencing System and Support Plan Tender

• Country: USA
• Summary: Next Generation Sequencing System and Support Plan
• UST Ref No: 123056940
• Deadline: 04 Aug 2025
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: NIAID-SS-25-2265418
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Description
  Sources Sought (SS) Notice
  Title: Next Generation Sequencing System and Support Plan
  ID: NIAID-SS-25-2265418
  Post Date: 07/18/2025
  Response Date: 08/04/2025
  Classification Code: 6640 - Laboratory Equipment and Supplies
  NAICS: 334516 Analytical Laboratory Instrument Manufacturing
  Introduction
  This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement.
  Project Summary
  The Viral Pathogenesis and Evolution Section (VPES) and The Clinical Studies Unit (CSU) within Laboratory of Infectious Diseases (LID) conducts research directed toward defining the causes and epidemiology of influenza and SARS-CoV-2 viral disease and developing means for their control, including universal influenza and SARS-CoV-2 vaccine development. VPES and CSU engages in a wide range of research activities that extends from clinical virology to molecular characterization of highly virulent influenza and SARS-CoV-2 viruses that cause severe, acute disease of the respiratory tracts in animal models to the development of novel vaccines and antiviral drugs. We also study immune responses and disease following human influenza viral challenge at the NIH Clinical Center. Scientists in the VPES employ high-throughput genomic, proteomic and machine learning computational approaches to elucidate pathogenesis of influenza disease, understand the response to infection, contagiousness, development of severe illness, as well as identify the molecular correlates of vaccine protection in animals and humans.
  NIAID-s ongoing projects utilizing Illumina high-throughput sequencing includes 1) clinical study, which focus on pandemic/seasonal influenza infections in patients, and characterizes the development of antiviral resistance mutations, intra-host viral e...
• Documents:

 Tender Notice